Lipid Solubility and Drug Penetration of the Blood Brain Barrier
The DOI matches its Crossref record.
Abstract
Lipid/water partition coefficients of 19 radiolabeled drugs were correlated with uptake by brain during a single microcirculatory passage following carotid arterial injection. Uptake was measured relative to a simultaneously injected diffusible reference. When the lipid/ water partition coefficient was greater than about 0.03 a substantial fraction of the drug penetrated the blood-brain barrier and for most drugs above this range, uptake was essentially complete. These data suggest there is probably little reason to greatly exceed this degree of lipid solubility when designing drugs for blood-brain barrier penetration and central nervous system effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,415
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204
Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction
Oates, J. A., Wood, A. J. J., & Benowitz, N. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192005 · Cited by 971
Characteristics of Compounds that Cross the Blood-Brain Barrier
Banks, W. A. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s3 · Cited by 710
“Most drugs cross the BBB by transmembrane diffusion [9].”
Poulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
The source of cerebral insulin
Banks, W. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.040 · Cited by 489
Transport of Steroid Hormones through the Rat Blood-Brain Barrier
Pardridge, W. M., & Mietus, L. J. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109433 · Cited by 444
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411
“However, all metal complexes of this ligand are positively charged and are, therefore, unlikely to penetrate the BBB.”
BackgroundInfluentialErickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 378
The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291
SHEN, D., ARTRU, A., & ADKISON, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.011 · Cited by 286
Design of iron chelators with therapeutic application
Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00050-4 · Cited by 287
Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge, W. M., Triguero, D., Yang, J., & Cancilla, P. A. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13060-7 · Cited by 275
Peptides and the blood–brain barrier
Banks, W. A. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.010 · Cited by 266
Design of clinically useful iron(III)‐selective chelators
Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266
Methodological issues in microdialysis sampling for pharmacokinetic studies
de Lange, E. C. M., de Boer, A. G., & Breimer, D. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00107-1 · Cited by 264
de Lange, E. C. M., & Danhof, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00001 · Cited by 244
Getting Drugs Across Biological Barriers
Yang, R., Wei, T., Goldberg, H., Wang, W., Cullion, K., & Kohane, D. S. (2017) · Advanced Materials · doi:10.1002/adma.201606596 · Cited by 234
Gut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
Molecular Anatomy of the Blood-Brain Barrier as Defined by Immunocytochemistry
Dermietzel, R., & Krause, D. (1991) · International Review of Cytology · doi:10.1016/s0074-7696(08)60692-0 · Cited by 239
Entry of Blood-Borne Cytokines into the Central Nervous System: Effects on Cognitive Processes
Banks, W. A., Farr, S. A., & Morley, J. E. (2002) · Neuroimmunomodulation · doi:10.1159/000071472 · Cited by 228
de Lange, E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00014-3 · Cited by 226
How to measure drug transport across the blood-brain barrier
Bickel, U. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.15 · Cited by 213
Milne, R. W., Nation, R. L., & Somogyi, A. A. (1996) · Drug Metabolism Reviews · doi:10.3109/03602539608994011 · Cited by 215
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs
Poulin, P., Schoenlein, K., & Theil, F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<436::aid-jps1002>3.0.co;2-p · Cited by 213
Methods for quantifying the transport of drugs across brain barrier systems
Fenstermacher, J. D., Blasberg, R. G., & Patlak, C. S. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90062-0 · Cited by 214
Metals ions and neurodegeneration
Molina-Holgado, F., Hider, R. C., Gaeta, A., Williams, R., & Francis, P. (2007) · BioMetals · doi:10.1007/s10534-006-9033-z · Cited by 207
Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors
van De Waterbeemd, H., Camenisch, G., Folkers, G., & Raevsky, O. A. (1996) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19960150604 · Cited by 200
Hair as a biomarker for exposure to tobacco smoke
Al-Delaimy, W. K. (2002) · Tobacco Control · doi:10.1136/tc.11.3.176 · Cited by 184
Hammarlund-Udenaes, M., Paalzow, L. K., & de Lange, E. C. M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012080106490 · Cited by 177
Blood–Brain Barrier Efflux Transport
Golden, P. L., & Pollack, G. M. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10424 · Cited by 174
Abacavir prodrugs: Microwave-assisted synthesis and their evaluation of anti-HIV activities
Sriram, D., Yogeeswari, P., Myneedu, N. S., & Saraswat, V. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.050 · Cited by 176
Potential role of ABC transporters as a detoxification system at the blood?CSF barrier
DELANGE, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.009 · Cited by 170
Letrent, S. P., Pollack, G. M., Brouwer, K. R., & Brouwer, K. L. R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)11822-3 · Cited by 169
Tsuji, A., Tamai, I., Sakata, A., Tenda, Y., & Terasaki, T. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90677-o · Cited by 166
Camenisch, G., Folkers, G., & van de Waterbeemd, H. (1996) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(96)00031-3 · Cited by 169
Nicotine and cotinine concentrations in serum and milk of nursing smokers.
Luck, W., & Nau, H. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb05014.x · Cited by 161
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems
Bodor, N. S., & Buchwald, P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00090-8 · Cited by 161
Banks, W. A. (2004) · Peptides · doi:10.1016/j.peptides.2004.02.014 · Cited by 181
Banks, W. A. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909021284 · Cited by 171
Bioavailability and Transport of Peptides and Peptide Drugs into the Brain
Egleton, R. D., & Davis, T. P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00242-8 · Cited by 169
In Vitro Blood–Brain Barrier Permeability of Nevirapine Compared to Other HIV Antiretroviral Agents
Glynn, S. L., & Yazdanian, M. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970291i · Cited by 147
Oldendorf, W. H. (1977) · Experimental Eye Research · doi:10.1016/s0014-4835(77)80016-x · Cited by 156
Self-citationThe effect of halogenation on blood–brain barrier permeability of a novel peptide drug☆
Gentry, C. L., Egleton, R. D., Gillespie, T., Abbruscato, T. J., Bechowski, H. B., Hruby, V. J., & Davis, T. P. (1999) · Peptides · doi:10.1016/s0196-9781(99)00127-8 · Cited by 150
Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological Diseases
Fiandaca, M. S., Forsayeth, J., Dickinson, P. J., & Bankiewicz, K. S. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.064 · Cited by 140
Oldendorf, W. H., & Braun, L. D. (1976) · Brain Research · doi:10.1016/0006-8993(76)90024-x · Cited by 139
Self-citationPhospholipids as Functional Constituents of Biomembranes
Eibl, H. (1984) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198402573 · Cited by 138
Design of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136
SU-8 based microprobes for simultaneous neural depth recording and drug delivery in the brain
Altuna, A., Bellistri, E., Cid, E., Aivar, P., Gal, B., Berganzo, J., Gabriel, G., Guimerà, A., Villa, R., Fernández, L. J., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc41364k · Cited by 129
Determinants of Passive Drug Entry into the Central Nervous System
Habgood, M. D., Begley, D. J., & Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007001923498 · Cited by 151
Banks, W. A., Farr, S. A., Butt, W., Kumar, V. B., Franko, M. W., & Morley, J. E. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29640-3 · Cited by 59
Smoking in patients with panic disorder
Pohl, R. B., Yeragani, V. K., Balon, R., Lycaki, H., & McBride, R. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90058-b · Cited by 132
de Lange, E. C. M. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-12 · Cited by 132
Newborn Rabbit Blood–Brain Barrier Is Selectively Permeable and Differs Substantially from the Adult
Braun, L. D., Cornford, E. M., & Oldendorf, W. H. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb04633.x · Cited by 124
Self-citationComparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults
Cornford, E. M., Braun, L. D., Oldendorf, W. H., & Hill, M. A. (1982) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1982.243.3.c161 · Cited by 117
Self-citationChen, M. Y., Hoffer, A., Morrison, P. F., Hamilton, J. F., Hughes, J., Schlageter, K. S., Lee, J., Kelly, B. R., & Oldfield, E. H. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.2.0311 · Cited by 118
Noy, N., Donnelly, T. M., & Zakim, D. (1986) · Biochemistry · doi:10.1021/bi00356a027 · Cited by 116
Age-related changes in the blood-brain barrier
Shah, G. N., & Mooradian, A. D. (1997) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00158-1 · Cited by 128
Iron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases
Whitnall, M., & Richardson, D. R. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.008 · Cited by 113
Wallis, W. J., & Simkin, P. A. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308060-00002 · Cited by 113
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1979) · Stroke · doi:10.1161/01.str.10.1.62 · Cited by 113
Kageyama, S., Mimoto, T., Murakawa, Y., Nomizu, M., Ford, H., Shirasaka, T., Gulnik, S., Erickson, J. W., Takada, K., & Hayashi, H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.810 · Cited by 110
Banks, W. A., Rhea, E. M., Reed, M. J., & Erickson, M. A. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101760 · Cited by 127
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Klein, A. K., Chatha, M., Laskowski, L. J., Anderson, E. I., Brandt, S. D., Chapman, S. J., McCorvy, J. D., & Halberstadt, A. L. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00176 · Cited by 109
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells
Letrent, S. P., Polli, J. W., Humphreys, J. E., Pollack, G. M., Brouwer, K. R., & Brouwer, K. L. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00180-x · Cited by 104
Porter, J., Morgan, J., Hoyes, K., Burke, L., Huehns, E., & Hider, R. (1990) · Blood · doi:10.1182/blood.v76.11.2389.2389 · Cited by 100
de Lange, E. C. M., Ravenstijn, P. G. M., Groenendaal, D., & van Steeg, T. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070354 · Cited by 97
The Blood-Brain Barrier in NeuroAIDS
Banks, W., Ercal, N., & Otamis Price, T. (2006) · Current HIV Research · doi:10.2174/157016206777709447 · Cited by 95
Levels of dopamine in blood and brain following nasal administration to rats
Dahlin, M., Jansson, B., & Björk, E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00151-8 · Cited by 97
Benowitz, N. L., Porchet, H. C., & Jacob, P. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62487-5 · Cited by 96
Fredenburg, A. M., Sethi, R. K., Allen, D. D., & Yokel, R. A. (1996) · Toxicology · doi:10.1016/0300-483x(95)03301-u · Cited by 94
Smoking and movement disorders in psychiatric patients
Menza, M. A., Grossman, N., Horn, M. V., Cody, R., & Forman, N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90163-g · Cited by 99
Drug transfer across the blood‐brain barrier and improvement of brain delivery
Jolliet, P., & Tillement, J. P. (1999) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00316.x · Cited by 91
Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics.
Porchet, H. C., Benowitz, N. L., Sheiner, L. B., & Copeland, J. R. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113227 · Cited by 88
How much do antiretroviral drugs penetrate into the central nervous system?
Ene, L., Duiculescu, D., & Ruta, S. M. (2011) · PubMed Central · Cited by 88
The potential application of iron chelators for the treatment of neurodegenerative diseases
Hider, R. C., Roy, S., Ma, Y. M., Le Kong, X., & Preston, J. (2011) · Metallomics · doi:10.1039/c0mt00087f · Cited by 83
van Bree, J. B. M. M., Audus, K. L., & Borchardt, R. T. (1988) · Pharmaceutical Research · doi:10.1023/a:1015959628008 · Cited by 85
Pogocki, D., Ruman, T., Danilczuk, M., Danilczuk, M., Celuch, M., & Wałajtys-Rode, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.038 · Cited by 92
Testosterone deficiency in non-cancer opioid-treated patients
Coluzzi, F., Billeci, D., Maggi, M., & Corona, G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0964-3 · Cited by 81
Carbamazepine uptake into rat brain following intra-olfactory transport
Barakat, N. S., Omar, S. A., & Ahmed, A. A. E. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.1.0008 · Cited by 81
Chemotherapy of brain metastases: Current status
Greig, N. H. (1984) · Cancer Treatment Reviews · doi:10.1016/0305-7372(84)90006-9 · Cited by 82
Microdialysis for pharmacokinetic analysis of drug transport to the brain
de Lange, E. C. M., de Boer, B. G., & Breimer, D. D. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00089-1 · Cited by 81
Zeiadeh, I., Najjar, A., & Karaman, R. (2018) · Molecules · doi:10.3390/molecules23061289 · Cited by 81
pH dependence of blood-brain barrier permeability to lactate and nicotine.
Oldendorf, W. H., Braun, L. D., & Cornford, E. M. (1979) · Stroke · doi:10.1161/01.str.10.5.577 · Cited by 79
Self-citationShah, M. V., Audus, K. L., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015913817221 · Cited by 78
(2005) · PubMed · Cited by 77
Penetration of the blood brain barrier by metronidazole and tinidazole
Jokipii, A. M. M., Myllylä, V. V., Hokkanen, E., & Jokipii, L. (1977) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/3.3.239 · Cited by 77
Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid
Bannwarth, B., Netter, P., Pourel, J., Royer, R., & Gaucher, A. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90140-6 · Cited by 77
Kolter, M., Ott, M., Hauer, C., Reimold, I., & Fricker, G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.005 · Cited by 75
Basic and Clinical Psychopharmacology of Nicotine
Houezec, J. L., & Benowitz, N. L. (1991) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00817-0 · Cited by 84
Banks, W. A., & Kastin, A. J. (1994) · Peptides · doi:10.1016/0196-9781(94)90165-1 · Cited by 72
Phospholipide als funktionelle Bausteine biologischer Membranen
Eibl, H. (1984) · Angewandte Chemie · doi:10.1002/ange.19840960404 · Cited by 72
Blood-Brain Barrier Equilibration of Codeine in Rats Studied with Microdialysis
Xie, R., & Hammarlund‐Udenaes, M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929910782 · Cited by 71
The Physiology of the Blood-Brain Barrier
Johansson, B. B. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_2 · Cited by 71
Raub, T., Barsuhn, C., Williams, L., Decker, D., Sawada, G., & Ho, N. (1993) · Journal of Drug Targeting · doi:10.3109/10611869308996085 · Cited by 70
Delivery of peptides to the brain: Emphasis on therapeutic development
Banks, W. A. (2008) · Peptide Science · doi:10.1002/bip.20980 · Cited by 68
Habgood, M. D., Liu, Z. D., Saghaei, L., Khodr, H., Abbott, J., & Hider, R. C. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00031-3 · Cited by 67
Clinical Pharmacokinetics of Cerebrospinal Fluid
Bonati, M. R., Kanto, J., & Tognoni, G. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207040-00003 · Cited by 67
Gallo, M., Defaus, S., & Andreu, D. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.010 · Cited by 69
Nicotine: A Review of Its Role in Atherosclerosis
Kilaru, S., Frangos, S., Chen, A. H., Gortler, D., Dhadwal, A. K., Araim, O., & Sumpio, B. E. (2001) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(01)01059-6 · Cited by 74
Metadata
- Authors
- Oldendorf, W. H.
- Affiliations
- United States Department of Veterans Affairs (US)
- Corresponding author
- Oldendorf, W. H.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 1974-12-01
- Volume
- 147
- Issue
- 3
- Pages
- 813-816
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W1964863479
- Semantic Scholar
- 473c8dc715f4a5fb06cc8d3f2c9178786b369d64
- Cited by
- 373
- References
- 0
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 9 · 2015: 11 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- blood-brain barrier, lipid solubility, lipid-water partition coefficient, drug penetration, brain uptake, radiolabeled drug
- MeSH terms
- Ethanol, Analgesics, Blood-Brain Barrier, Carbon Radioisotopes, Lipids, Phenytoin, Solubility, Tritium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.